Annual EBITDA
-$70.45 M
-$78.86 M-938.54%
31 December 2023
Summary:
Oncology Institute annual earnings before interest, taxes, depreciation & amortization is currently -$70.45 million, with the most recent change of -$78.86 million (-938.54%) on 31 December 2023. During the last 3 years, it has fallen by -$59.16 million (-524.04%). TOI annual EBITDA is now -938.54% below its all-time high of $8.40 million, reached on 31 December 2022.TOI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$12.31 M
-$472.00 K-3.99%
30 September 2024
Summary:
Oncology Institute quarterly earnings before interest, taxes, depreciation & amortization is currently -$12.31 million, with the most recent change of -$472.00 thousand (-3.99%) on 30 September 2024. Over the past year, it has increased by +$1.52 million (+10.96%). TOI quarterly EBITDA is now -159.99% below its all-time high of $20.53 million, reached on 31 March 2022.TOI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$56.12 M
+$1.52 M+2.63%
30 September 2024
Summary:
Oncology Institute TTM earnings before interest, taxes, depreciation & amortization is currently -$56.12 million, with the most recent change of +$1.52 million (+2.63%) on 30 September 2024. Over the past year, it has increased by +$6.51 million (+10.40%). TOI TTM EBITDA is now -549.34% below its all-time high of $12.49 million, reached on 31 March 2022.TOI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOI EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -938.5% | +11.0% | +10.4% |
| 3 y3 years | -524.0% | -882.8% | -445.9% |
| 5 y5 years | - | -2937.7% | -10000.0% |
TOI EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -938.5% | at low | -160.0% | +54.8% | -549.3% | +20.3% |
| 5 y | 5 years | -938.5% | at low | -160.0% | +54.8% | -549.3% | +20.3% |
| alltime | all time | -938.5% | at low | -160.0% | +54.8% | -549.3% | +20.3% |
Oncology Institute EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.31 M(+4.0%) | -$56.12 M(-2.6%) |
| June 2024 | - | -$11.84 M(-27.9%) | -$57.64 M(-3.3%) |
| Mar 2024 | - | -$16.41 M(+5.6%) | -$59.63 M(-15.4%) |
| Dec 2023 | -$70.45 M(-938.5%) | -$15.55 M(+12.4%) | -$70.45 M(+12.5%) |
| Sept 2023 | - | -$13.83 M(0.0%) | -$62.64 M(+28.2%) |
| June 2023 | - | -$13.83 M(-49.2%) | -$48.87 M(+24.1%) |
| Mar 2023 | - | -$27.24 M(+252.3%) | -$39.37 M(-568.5%) |
| Dec 2022 | $8.40 M | -$7.73 M(>+9900.0%) | $8.40 M(+87.1%) |
| Sept 2022 | - | -$67.00 K(-98.5%) | $4.49 M(+35.9%) |
| June 2022 | - | -$4.33 M(-121.1%) | $3.30 M(-73.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $20.53 M(-276.3%) | $12.49 M(-257.4%) |
| Dec 2021 | -$7.94 M(-29.7%) | -$11.64 M(+829.3%) | -$7.94 M(-22.8%) |
| Sept 2021 | - | -$1.25 M(-125.8%) | -$10.28 M(+11.4%) |
| June 2021 | - | $4.86 M(+4760.0%) | -$9.23 M(-23.9%) |
| Mar 2021 | - | $100.00 K(-100.7%) | -$12.13 M(-0.8%) |
| Dec 2020 | -$11.29 M(-3776.3%) | -$13.99 M(+6946.4%) | -$12.23 M(-794.4%) |
| Sept 2020 | - | -$198.50 K(-110.1%) | $1.76 M(-10.1%) |
| June 2020 | - | $1.96 M(-583.3%) | $1.96 M(-583.3%) |
| Dec 2019 | $307.10 K | - | - |
| Dec 2018 | - | -$405.40 K | -$405.40 K |
FAQ
- What is Oncology Institute annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Oncology Institute?
- What is Oncology Institute annual EBITDA year-on-year change?
- What is Oncology Institute quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Oncology Institute?
- What is Oncology Institute quarterly EBITDA year-on-year change?
- What is Oncology Institute TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Oncology Institute?
- What is Oncology Institute TTM EBITDA year-on-year change?
What is Oncology Institute annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of TOI is -$70.45 M
What is the all time high annual EBITDA for Oncology Institute?
Oncology Institute all-time high annual earnings before interest, taxes, depreciation & amortization is $8.40 M
What is Oncology Institute annual EBITDA year-on-year change?
Over the past year, TOI annual earnings before interest, taxes, depreciation & amortization has changed by -$78.86 M (-938.54%)
What is Oncology Institute quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of TOI is -$12.31 M
What is the all time high quarterly EBITDA for Oncology Institute?
Oncology Institute all-time high quarterly earnings before interest, taxes, depreciation & amortization is $20.53 M
What is Oncology Institute quarterly EBITDA year-on-year change?
Over the past year, TOI quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.52 M (+10.96%)
What is Oncology Institute TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of TOI is -$56.12 M
What is the all time high TTM EBITDA for Oncology Institute?
Oncology Institute all-time high TTM earnings before interest, taxes, depreciation & amortization is $12.49 M
What is Oncology Institute TTM EBITDA year-on-year change?
Over the past year, TOI TTM earnings before interest, taxes, depreciation & amortization has changed by +$6.51 M (+10.40%)